ArticleJMIR research protocols2026

Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.

Katrina M Oselinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.